SPECIAL REPORT 24.02
2024 Perspectives for Biotechnology Companies
For many, if not for most biotechnology companies, 2023 has been a dreadful and frustrating year.
Annus horribilis
said the CEO of one of them, who had to restructure his organisation with drastic job cuts and who barely survived. Reasons were